UniProt ID | AMRP_HUMAN | |
---|---|---|
UniProt AC | P30533 | |
Protein Name | Alpha-2-macroglobulin receptor-associated protein | |
Gene Name | LRPAP1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 357 | |
Subcellular Localization | Rough endoplasmic reticulum lumen . Endoplasmic reticulum-Golgi intermediate compartment lumen . Golgi apparatus, cis-Golgi network . Golgi apparatus lumen . Endosome lumen . Cell surface . May be associated with receptors at the cell surface. | |
Protein Description | Molecular chaperone for LDL receptor-related proteins that may regulate their ligand binding activity along the secretory pathway.. | |
Protein Sequence | MAPRRVRSFLRGLPALLLLLLFLGPWPAASHGGKYSREKNQPKPSPKRESGEEFRMEKLNQLWEKAQRLHLPPVRLAELHADLKIQERDELAWKKLKLDGLDEDGEKEARLIRNLNVILAKYGLDGKKDARQVTSNSLSGTQEDGLDDPRLEKLWHKAKTSGKFSGEELDKLWREFLHHKEKVHEYNVLLETLSRTEEIHENVISPSDLSDIKGSVLHSRHTELKEKLRSINQGLDRLRRVSHQGYSTEAEFEEPRVIDLWDLAQSANLTDKELEAFREELKHFEAKIEKHNHYQKQLEIAHEKLRHAESVGDGERVSRSREKHALLEGRTKELGYTVKKHLQDLSGRISRARHNEL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
35 | Phosphorylation | AASHGGKYSREKNQP CHHCCHHCCCCCCCC | 19.08 | 26437602 | |
36 | Phosphorylation | ASHGGKYSREKNQPK HHCCHHCCCCCCCCC | 37.13 | 26437602 | |
43 | Ubiquitination | SREKNQPKPSPKRES CCCCCCCCCCCCCCC | 48.65 | 24816145 | |
45 | Phosphorylation | EKNQPKPSPKRESGE CCCCCCCCCCCCCCH | 49.53 | 20068231 | |
50 | Phosphorylation | KPSPKRESGEEFRME CCCCCCCCCHHHHHH | 56.38 | 29255136 | |
65 | 2-Hydroxyisobutyrylation | KLNQLWEKAQRLHLP HHHHHHHHHHHCCCC | 37.93 | - | |
84 | Ubiquitination | AELHADLKIQERDEL HHHHCCCCCHHHHHH | 42.78 | 33845483 | |
97 | Sumoylation | ELAWKKLKLDGLDED HHHHHHHHCCCCCCC | 54.11 | - | |
97 | 2-Hydroxyisobutyrylation | ELAWKKLKLDGLDED HHHHHHHHCCCCCCC | 54.11 | - | |
97 | Sumoylation | ELAWKKLKLDGLDED HHHHHHHHCCCCCCC | 54.11 | 17000644 | |
122 | Phosphorylation | LNVILAKYGLDGKKD HHHHHHHHCCCCCCC | 19.81 | 28985074 | |
127 | 2-Hydroxyisobutyrylation | AKYGLDGKKDARQVT HHHCCCCCCCHHHHH | 47.34 | - | |
134 | O-linked_Glycosylation | KKDARQVTSNSLSGT CCCHHHHHHCCCCCC | 17.53 | 55828577 | |
134 | Phosphorylation | KKDARQVTSNSLSGT CCCHHHHHHCCCCCC | 17.53 | - | |
135 | Phosphorylation | KDARQVTSNSLSGTQ CCHHHHHHCCCCCCC | 26.09 | - | |
137 | Phosphorylation | ARQVTSNSLSGTQED HHHHHHCCCCCCCCC | 24.55 | 25159151 | |
139 | Phosphorylation | QVTSNSLSGTQEDGL HHHHCCCCCCCCCCC | 39.35 | 25627689 | |
141 | Phosphorylation | TSNSLSGTQEDGLDD HHCCCCCCCCCCCCC | 25.96 | 25159151 | |
153 | Ubiquitination | LDDPRLEKLWHKAKT CCCHHHHHHHHHHHH | 62.56 | 29967540 | |
161 | Phosphorylation | LWHKAKTSGKFSGEE HHHHHHHCCCCCHHH | 39.00 | 24719451 | |
163 | Acetylation | HKAKTSGKFSGEELD HHHHHCCCCCHHHHH | 35.80 | 27452117 | |
165 | Phosphorylation | AKTSGKFSGEELDKL HHHCCCCCHHHHHHH | 49.10 | 22798277 | |
180 | 2-Hydroxyisobutyrylation | WREFLHHKEKVHEYN HHHHHHHHHHHHHHH | 48.78 | - | |
186 | Phosphorylation | HKEKVHEYNVLLETL HHHHHHHHHHHHHHH | 8.83 | - | |
225 | 2-Hydroxyisobutyrylation | HSRHTELKEKLRSIN HHCHHHHHHHHHHHH | 46.71 | - | |
227 | Ubiquitination | RHTELKEKLRSINQG CHHHHHHHHHHHHHH | 47.84 | 24816145 | |
230 | Phosphorylation | ELKEKLRSINQGLDR HHHHHHHHHHHHHHH | 36.01 | 20068231 | |
242 | Phosphorylation | LDRLRRVSHQGYSTE HHHHHHHHCCCCCCC | 14.31 | 29255136 | |
246 | Phosphorylation | RRVSHQGYSTEAEFE HHHHCCCCCCCCCCC | 13.07 | 29255136 | |
247 | Phosphorylation | RVSHQGYSTEAEFEE HHHCCCCCCCCCCCC | 26.96 | 29255136 | |
248 | Phosphorylation | VSHQGYSTEAEFEEP HHCCCCCCCCCCCCC | 30.63 | 29255136 | |
268 | N-linked_Glycosylation | WDLAQSANLTDKELE HHHHHHCCCCHHHHH | 49.04 | 19159218 | |
287 | Acetylation | ELKHFEAKIEKHNHY HHHHHHHHHHHCCHH | 44.17 | 19608861 | |
304 | Ubiquitination | QLEIAHEKLRHAESV HHHHHHHHHHHCHHH | 40.74 | 29967540 | |
304 | 2-Hydroxyisobutyrylation | QLEIAHEKLRHAESV HHHHHHHHHHHCHHH | 40.74 | - | |
310 | Phosphorylation | EKLRHAESVGDGERV HHHHHCHHHCCCCCC | 31.98 | 28355574 | |
323 | Acetylation | RVSRSREKHALLEGR CCCHHHHHHHHHHCC | 32.82 | 27452117 | |
323 | Ubiquitination | RVSRSREKHALLEGR CCCHHHHHHHHHHCC | 32.82 | 33845483 | |
331 | O-linked_Glycosylation | HALLEGRTKELGYTV HHHHHCCHHHHCHHH | 39.46 | OGP | |
332 | Ubiquitination | ALLEGRTKELGYTVK HHHHCCHHHHCHHHH | 49.97 | 23000965 | |
332 | 2-Hydroxyisobutyrylation | ALLEGRTKELGYTVK HHHHCCHHHHCHHHH | 49.97 | - | |
336 | Phosphorylation | GRTKELGYTVKKHLQ CCHHHHCHHHHHHHH | 22.45 | 28152594 | |
337 | O-linked_Glycosylation | RTKELGYTVKKHLQD CHHHHCHHHHHHHHH | 24.85 | 55831075 | |
337 | Phosphorylation | RTKELGYTVKKHLQD CHHHHCHHHHHHHHH | 24.85 | 28152594 | |
339 | 2-Hydroxyisobutyrylation | KELGYTVKKHLQDLS HHHCHHHHHHHHHHC | 27.03 | - | |
340 | Acetylation | ELGYTVKKHLQDLSG HHCHHHHHHHHHHCH | 45.25 | 27452117 | |
346 | O-linked_Glycosylation | KKHLQDLSGRISRAR HHHHHHHCHHHHHHH | 34.02 | 55828359 | |
346 | Phosphorylation | KKHLQDLSGRISRAR HHHHHHHCHHHHHHH | 34.02 | 27251275 | |
348 | Methylation | HLQDLSGRISRARHN HHHHHCHHHHHHHHC | 21.97 | 115482273 | |
350 | Phosphorylation | QDLSGRISRARHNEL HHHCHHHHHHHHCCC | 20.66 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AMRP_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AMRP_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AMRP_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
LRP8_HUMAN | LRP8 | physical | 12899622 | |
VLDLR_HUMAN | VLDLR | physical | 12899622 | |
DPOA2_HUMAN | POLA2 | physical | 16169070 | |
RTN4_HUMAN | RTN4 | physical | 16169070 | |
VLDLR_HUMAN | VLDLR | physical | 10571241 | |
RAF1_HUMAN | RAF1 | physical | 10783161 | |
GNDS_HUMAN | RALGDS | physical | 10783161 | |
SORL_HUMAN | SORL1 | physical | 8940146 | |
SORL_HUMAN | SORL1 | physical | 11557679 | |
4EBP1_HUMAN | EIF4EBP1 | physical | 16798736 | |
MTOR_HUMAN | MTOR | physical | 16798736 | |
LRP2_HUMAN | LRP2 | physical | 7512726 | |
VLDLR_HUMAN | VLDLR | physical | 28514442 | |
LRP1B_HUMAN | LRP1B | physical | 28514442 | |
LRP4_HUMAN | LRP4 | physical | 28514442 | |
SORL_HUMAN | SORL1 | physical | 28514442 | |
ROCK2_HUMAN | ROCK2 | physical | 28514442 | |
LDLR_HUMAN | LDLR | physical | 28514442 | |
LRP8_HUMAN | LRP8 | physical | 28514442 | |
LRP1_HUMAN | LRP1 | physical | 28514442 | |
LRP2_HUMAN | LRP2 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
615431 | Myopia 23, autosomal recessive (MYP23) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-287, AND MASS SPECTROMETRY. | |
N-linked Glycosylation | |
Reference | PubMed |
"Glycoproteomics analysis of human liver tissue by combination ofmultiple enzyme digestion and hydrazide chemistry."; Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.; J. Proteome Res. 8:651-661(2009). Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-268, AND MASSSPECTROMETRY. |